ROMSO Cyprus Knowledge Base
Hinokitiol
Hinokitiol (β-thujaplicin) is a natural monoterpenoid found in the wood of trees belonging to the Cupressaceae family. It is a tropolone derivative and one of the thujaplicins. Hinokitiol is widely used in oral care products and medications due to its broad spectrum of antimicrobial and anti-inflammatory properties. In addition, it is approved as a food additive.
The name "Hinokitiol" originated from the fact that it was first isolated in 1936 from Hinoki trees in Taiwan. It is almost absent in Japanese Hinoki trees, but found in high quantities (about 0.04% of heartwood weight) in Juniperus cedarus, Himalayan cedar wood (Cedrus deodara), and Western red cedar (Thuja plicata). It can be easily extracted from cedar with solvents or ultrasonication.
Hinokitiol is structurally related to tropolone, which lacks an isopropyl substituent. Tropolones are well-known chelating agents.
Antimicrobial Process
Hinokitiol has a wide range of biological activities, many of which have been identified and emphasized in the literature. The first and best-studied activity is its potent antimicrobial process against various bacteria and fungi (fungi) without regard to antibiotic resistance. Specifically, hinokitiol has shown effectiveness against Streptococcus pneumoniae, Streptococcus mutans, and Staphylococcus aureus, common human pathogens. In addition, it has been observed that hinokitiol exerts a suppressive effect on Chlamydia trachomatis and can be used as a topical medication. Recent studies have also shown that when used in combination with zinc compounds, hinokitiol exhibits antiviral properties against several human viruses, including rhinovirus, coxsackievirus, and mumps virus.
Other Activities
In addition to its broad spectrum of antimicrobial properties, hinokitiol has anti-inflammatory and anticancer activities, which have been observed in various in vitro cell studies and in vivo animal studies. Hinokitiol contains major inflammatory markers such as TNF-alpha and NF-kappaB, and its potential for treating chronic inflammation or autoimmune conditions is being explored. Hinokitiol also exhibits cytotoxic effects on several major cancer cells by inducing autophagic processes.
Coronavirus Research
The antiviral effects of hinokitiol are generated through its action as a zinc ionophore. Hinokitiol enables the flow of zinc ions into cells, which inhibits the RNA virus replication machinery, thereby blocking viral replication (multiplication). Notable examples of RNA viruses include human influenza virus, SARS, and novel coronavirus. A study demonstrated the effectiveness of zinc ionophores in inhibiting SARS replication when combined with zinc ions.
Note: The text has been translated directly from Hindi to English without any changes or additions.